Co-Diagnostics (CODX) Competitors $0.36 +0.01 (+1.99%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CODX vs. MODD, ECOR, BDMD, TELA, DXR, APYX, MDAI, DRIO, POCI, and FEMYShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include Modular Medical (MODD), electroCore (ECOR), Baird Medical Investment (BDMD), TELA Bio (TELA), Daxor (DXR), Apyx Medical (APYX), Spectral AI (MDAI), DarioHealth (DRIO), Precision Optics (POCI), and Femasys (FEMY). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. Modular Medical electroCore Baird Medical Investment TELA Bio Daxor Apyx Medical Spectral AI DarioHealth Precision Optics Femasys Modular Medical (NASDAQ:MODD) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Which has better valuation and earnings, MODD or CODX? Modular Medical has higher earnings, but lower revenue than Co-Diagnostics. Modular Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModular MedicalN/AN/A-$17.47M-$0.53-1.97Co-Diagnostics$3.92M3.07-$35.33M-$1.24-0.29 Is MODD or CODX more profitable? Modular Medical has a net margin of 0.00% compared to Co-Diagnostics' net margin of -563.93%. Co-Diagnostics' return on equity of -54.94% beat Modular Medical's return on equity.Company Net Margins Return on Equity Return on Assets Modular MedicalN/A -197.97% -162.31% Co-Diagnostics -563.93%-54.94%-49.28% Do insiders & institutionals have more ownership in MODD or CODX? 27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 20.5% of Modular Medical shares are owned by company insiders. Comparatively, 6.1% of Co-Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community prefer MODD or CODX? Co-Diagnostics received 273 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 62.93% of users gave Co-Diagnostics an outperform vote. CompanyUnderperformOutperformModular MedicalOutperform Votes2100.00% Underperform VotesNo VotesCo-DiagnosticsOutperform Votes27562.93% Underperform Votes16237.07% Does the media prefer MODD or CODX? In the previous week, Co-Diagnostics had 5 more articles in the media than Modular Medical. MarketBeat recorded 8 mentions for Co-Diagnostics and 3 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.16 beat Co-Diagnostics' score of 0.79 indicating that Modular Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Modular Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Co-Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, MODD or CODX? Modular Medical has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Do analysts recommend MODD or CODX? Co-Diagnostics has a consensus price target of $5.50, indicating a potential upside of 1,436.31%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe Co-Diagnostics is more favorable than Modular Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryCo-Diagnostics beats Modular Medical on 11 of the 18 factors compared between the two stocks. Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.02M$4.37B$5.53B$7.99BDividend YieldN/A39.94%5.11%4.23%P/E Ratio-0.2630.8122.6518.64Price / Sales3.0755.50401.98103.80Price / CashN/A51.0838.1834.62Price / Book0.136.096.754.30Net Income-$35.33M$68.71M$3.22B$248.44M7 Day Performance-0.56%-0.18%1.66%1.81%1 Month Performance9.21%-2.33%4.17%4.40%1 Year Performance-69.92%23.51%16.17%5.97% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics4.324 of 5 stars$0.36+2.0%$5.50+1,436.3%-69.7%$12.02M$3.92M-0.26100Upcoming EarningsAnalyst ForecastNews CoverageGap UpMODDModular Medical1.9626 of 5 stars$1.02+9.7%N/A-31.6%$41.48MN/A-1.9220Short Interest ↓Negative NewsECORelectroCore2.4001 of 5 stars$7.38-2.5%$25.50+245.5%+20.3%$40.71M$25.18M-4.0350Upcoming EarningsNews CoveragePositive NewsBDMDBaird Medical InvestmentN/A$5.95+4.2%N/AN/A$39.18M$33.05M0.00N/ATELATELA Bio2.9792 of 5 stars$0.960.0%$7.25+655.8%-78.5%$37.95M$69.30M-0.57120Upcoming EarningsShort Interest ↓DXRDaxor3.998 of 5 stars$7.52-4.0%$25.00+232.4%-23.8%$36.37M$2.13M0.0037Gap UpAPYXApyx Medical1.3954 of 5 stars$0.90+1.1%N/A-27.3%$34.02M$48.10M-1.08270Upcoming EarningsShort Interest ↑News CoverageGap DownMDAISpectral AI2.9806 of 5 stars$1.30+3.2%$4.75+265.4%-27.0%$32.91M$29.58M-2.0083Upcoming EarningsShort Interest ↓News CoverageGap DownDRIODarioHealth2.5467 of 5 stars$0.79-1.7%$1.50+90.8%-49.6%$32.68M$27.04M-0.84200News CoveragePositive NewsPOCIPrecision Optics0.6287 of 5 stars$4.24-1.3%N/A-20.7%$32.47M$18.68M-6.6280Positive NewsGap UpHigh Trading VolumeFEMYFemasys3.4127 of 5 stars$1.16-5.7%$11.50+891.4%-8.7%$31.49M$1.63M-1.4330Upcoming EarningsShort Interest ↓Gap Down Related Companies and Tools Related Companies MODD Competitors ECOR Competitors BDMD Competitors TELA Competitors DXR Competitors APYX Competitors MDAI Competitors DRIO Competitors POCI Competitors FEMY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CODX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CODX Stock Free CODX Stock Alerts